Table 7.

Logistic regression analysis of associations of persistent HPV detection with CD4 counts (at enrollment) and characteristics of HIV-infected women (n = 98).

Variables	Any HPVa		HR-HPVb		IARC HR-HPVc		LR-HPVd
	OR (95% CI)	p-value	OR (95% CI)	p-value	OR (95% CI)	p-value	OR (95% CI)	p-value
CD4 ⩽ 200 cells/µL (n = 9 women)	1	–	1	–	1	–	1	–
CD4 201–350 cells/µL (n = 13 women)	0.06 (0.00–0.72)	0.027	0.18 (0.02–1.48)	0.110	0.09 (0.01–0.93)	0.043	0.21 (0.03–1.65)	0.136
CD4 351–500 cells/µL (n = 17 women)	0.17 (0.01–1.92)	0.151	0.23 (0.03–1.62)	0.140	0.20 (0.03–1.44)	0.109	0.18 (0.03–1.27)	0.086
CD4 > 500 cells/µL (n = 59 women)	0.11 (0.01–1.02)	0.053	0.16 (0.03–0.91)	0.039	0.16 (0.03–0.89)	0.037	0.15 (0.03–0.86)	0.033
Age	1.00 (0.92–1.08)	0.906	0.94 (0.86–1.01)	0.109	0.93 (0.85–1.01)	0.086	1.06 (0.97–1.16)	0.198
Married	0.47 (0.17–1.33)	0.154	0.41 (0.13–1.28)	0.125	0.34 (0.09–1.21)	0.095	0.46 (0.14–1.50)	0.199
More than secondary school education	0.64 (0.13–3.17)	0.581	0.70 (0.12–4.02)	0.687	0.39 (0.04–3.66)	0.406	0.89 (0.14–5.56)	0.896
Home ownership	0.49 (0.13–1.92)	0.308	0.47 (0.10–2.16)	0.335	0.68 (0.14–3.28)	0.629	0.39 (0.08–2.01)	0.262
Walking distance to health care ⩾ 60 min	1.61 (0.45–5.81)	0.467	1.63 (0.44–5.95)	0.462	1.52 (0.39–5.93)	0.550	1.44 (0.38–5.37)	0.590
Number of lifetime sex partners	1.01 (0.98–1.05)	0.423	0.96 (0.89–1.04)	0.293	0.97 (0.89–1.05)	0.397	1.02 (0.98–1.07)	0.288
Age of first sex	1.13 (0.94–1.35)	0.199	1.02 (0.84–1.24)	0.836	1.06 (0.86–1.31)	0.589	1.16 (0.95–1.41)	0.136

HPV: human papillomaviruses; IARC: International Agency for the Research on Cancer; OR: odds ratio; CI: confidence interval.

^aAny HPV: HPV 16,18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 67, 68, 69, 70, 73, 82, IS39.

^bHR-HPV (high-risk HPV): HPV 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 67, 68, 69, 70, 73, 82, IS39.

^cIARC HR-HPV: HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66.

^dLR-HPV (low-risk HPV): HPV 6, 11, 40, 42, 54, 55, 61, 62, 64, 71, 72, 81, 83, 84, CP6108.